EKIMAS Corp (ASNB) financial statements (2022 and earlier)
Company profile
| Business Address |
95 WASHINGTON STREET #154 CANTON, MA 02021 |
| State of Incorp. | DE |
| Fiscal Year End | March 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 122 | 128 | 5,538 | 0 | 120 | 27 | 80 | ||
| Cash and cash equivalents | 122 | 128 | 5,538 | 0 | 120 | 27 | 80 | ||
| Receivables | 63 | 0 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 0 | 297 | 189 | 257 | |||||
| Inventory | 0 | 297 | 189 | 257 | |||||
| Prepaid expense | 0 | ||||||||
| Other undisclosed current assets | 8 | 0 | 574 | 238 | 197 | ||||
| Total current assets: | 122 | 128 | 5,609 | 1 | 991 | 454 | 534 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2 | 1,823 | 1,865 | 1,922 | |||||
| Deposits noncurrent assets | 0 | ||||||||
| Other undisclosed noncurrent assets | 0 | 106 | 113 | 120 | |||||
| Total noncurrent assets: | 2 | 1,929 | 1,978 | 2,042 | |||||
| TOTAL ASSETS: | 122 | 128 | 5,609 | 3 | 2,920 | 2,432 | 2,576 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 74 | 46 | 45 | 1 | |||||
| Accounts payable | 0 | ||||||||
| Accrued liabilities | 0 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 74 | 46 | 45 | ||||||
| Deferred revenue | 69 | ✕ | ✕ | ✕ | ✕ | ||||
| Customer advances and deposits | ✕ | ✕ | ✕ | ✕ | 295 | 7 | 42 | ||
| Other undisclosed current liabilities | 0 | 967 | 868 | 484 | |||||
| Total current liabilities: | 74 | 46 | 114 | 1 | 1,262 | 875 | 526 | ||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 160 | ||||||||
| Accounts payable and accrued liabilities | 160 | ||||||||
| Other undisclosed noncurrent liabilities | 2 | 2,161 | 2,158 | 1,986 | |||||
| Total noncurrent liabilities: | 2 | 2,161 | 2,158 | 2,146 | |||||
| Total liabilities: | 74 | 46 | 114 | 3 | 3,423 | 3,033 | 2,672 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 48 | 82 | 5,495 | (0) | (503) | (601) | (96) | ||
| Common stock | 49 | 28 | 28 | 0 | 21 | 21 | 21 | ||
| Treasury stock, value | (30) | (30) | (30) | 30 | 30 | 30 | |||
| Additional paid in capital | 33,701 | 33,522 | 38,609 | 38 | 38,404 | 38,104 | 38,100 | ||
| Accumulated deficit | (33,672) | (33,438) | (33,112) | (39) | (38,898) | (38,696) | (38,187) | ||
| Other undisclosed stockholders' equity attributable to parent | (60) | (60) | (60) | ||||||
| Other undisclosed stockholders' equity | (0) | ||||||||
| Total stockholders' equity: | 48 | 82 | 5,495 | (0) | (503) | (601) | (96) | ||
| TOTAL LIABILITIES AND EQUITY: | 122 | 128 | 5,609 | 3 | 2,920 | 2,432 | 2,576 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3 | 2,918 | 2,284 | |||||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 2,918 | 2,284 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (1) | (799) | (853) | (85,000) | ||||
| Gross profit: | 2 | 2,119 | 1,431 | (85,000) | ||||
| Operating expenses | (767) | (326) | (246) | (2) | (1,938) | (1,572) | (310,000) | |
| Operating income (loss): | (767) | (326) | (246) | 1 | 181 | (141) | (395,000) | |
| Nonoperating income (Investment Income, Nonoperating) | 1 | |||||||
| Interest and debt expense | (383) | (368) | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (767) | (326) | (246) | 2 | (202) | (509) | (395,000) | |
| Other undisclosed income (loss) from continuing operations before income taxes | 370 | (1) | ||||||
| Income (loss) from continuing operations before income taxes: | (397) | (326) | (246) | 0 | (202) | (509) | (395,000) | |
| Other undisclosed income from continuing operations | 22 | |||||||
| Income (loss) from continuing operations: | (375) | (326) | (246) | 0 | (202) | (509) | (395,000) | |
| Income from discontinued operations | 5,698 | |||||||
| Other undisclosed loss before gain (loss) on sale of properties | (129) | |||||||
| Net income (loss): | (504) | (326) | 5,452 | 0 | (202) | (509) | (395,000) | |
| Other undisclosed net income attributable to parent | 395,033 | |||||||
| Net income (loss) available to common stockholders, diluted: | (504) | (326) | 5,452 | 0 | (202) | (509) | 33 | |
Comprehensive Income ($ in thousands)
| 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (504) | (326) | 5,452 | 0 | (202) | (509) | (395,000) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (504) | (326) | 5,452 | 0 | (202) | (509) | (395,000) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.